SenesTech, Inc. reported its financial results for the first quarter of 2025, revealing a net revenue of $485,000, a 17% increase from $415,000 in the same period last year. The company attributed this growth primarily to the successful launch of its Evolve product line, which includes Evolve Rat and Evolve Mouse, contributing approximately 79% of total revenues. Despite the increase in revenue, SenesTech continues to face challenges, posting a net loss of $1.7 million for the quarter, slightly improved from a loss of $1.8 million in the first quarter of 2024.
The company's total assets rose to $3.6 million as of March 31, 2025, compared to $3.3 million at the end of 2024. This increase was driven by higher cash and cash equivalents, which reached $1.7 million, up from $1.3 million. The company’s accumulated deficit also grew to $137.8 million, reflecting ongoing operational losses since its inception. Operating expenses remained stable at approximately $2 million, with research and development costs increasing slightly to $418,000, while selling, general, and administrative expenses decreased marginally to $1.6 million.
In terms of operational developments, SenesTech has expanded its product offerings with the Evolve line, which is designed to manage pest populations through fertility control. The Evolve Rat product was launched in January 2024, and Evolve Mouse followed in May 2024. The company is actively pursuing regulatory approvals to broaden the marketability of its products, which are now registered in 48 states for Evolve Rat and 35 states for Evolve Mouse. The company’s workforce has also seen changes, with a reduction in headcount contributing to lower personnel-related expenses.
Looking ahead, SenesTech anticipates that it will continue to incur significant operating losses in the near future. The company expects its current cash reserves, combined with anticipated revenue and potential equity sales, will be sufficient to fund operations for at least the next four months. However, management has indicated that additional financing will be necessary to support ongoing commercialization efforts and to achieve anticipated revenue targets. The company remains focused on enhancing its product lines and expanding its market presence, while also navigating the challenges of maintaining financial stability.
About SenesTech, Inc.
About 10-Q Filings
A 10-Q form is an important financial report that public companies in the United States must submit every three months. It gives a clear picture of a company's financial health and recent performance.
Key points about the 10-Q:
- Frequency: Companies file it three times a year, covering the first three quarters. The fourth quarter is covered in a more comprehensive annual report.
-
Content: It includes:
- Financial statements showing the company's current financial position
- Updates from management on the performance and projections of the business
- Information about potential risks the company faces
- Details on how the company is run internally
- Deadline: Must be filed within 40 or 45 days after the quarter ends, depending on the size of the company.
Our Methodology
AssetRoom is committed to providing timely summaries of news from public companies. We use AI to generate these summaries quickly, but they are not reviewed by human experts.
Our method:
- Data Collection: We continuously monitor for new filings (currently limited to US-listed stocks).
- AI-Powered Analysis: Our advanced AI system processes each filing, identifying key information and extracting relevant data.
- Summary Generation: The AI creates a concise, easy-to-understand summary of the filing, highlighting the most important points.
- Publication: The summary is immediately published on our platform, allowing users instant access to the latest information.
- Email users: We distribute round-up emails according to our users preferences, keeping them in the loop with the companies they follow.
Feedback & Corrections
Spot an error or have a suggestion? Contact us.